XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.23.3

REVENUE (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Revenue from Contract with Customer [Abstract] |
Schedule of Total Revenue by Type and by U.S versus Rest of World | The following table presents detail regarding the composition of the Company’s total revenue by product type and by geographical region, either U.S. or rest of world (“RoW”):
| Three months ended September 30,
| 2023 |  |  | 2022
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Testing revenues: |  |  |  |  |  |  |  |  |  |  |  |
Hereditary Cancer | $ | 75.1 |  |  | $ | 11.4 |  |  | $ | 86.5 |  |  |  | $ | 60.2 |  |  | $ | 10.3 |  |  | $ | 70.5 |
Tumor Profiling | 22.0 |  |  | 8.2 |  |  | 30.2 |  |  |  | 20.2 |  |  | 10.6 |  |  | 30.8 |
Prenatal | 39.4 |  |  | 0.1 |  |  | 39.5 |  |  |  | 21.9 |  |  | 0.2 |  |  | 22.1 |
Pharmacogenomics | 35.7 |  |  | — |  |  | 35.7 |  |  |  | 33.0 |  |  | — |  |  | 33.0 |
Total revenue | $ | 172.2 |  |  | $ | 19.7 |  |  | $ | 191.9 |  |  |  | $ | 135.3 |  |  | $ | 21.1 |  |  | $ | 156.4 |
| Nine months ended September 30,
| 2023 |  |  | 2022
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Testing revenues: |  |  |  |  |  |  |  |  |  |  |  |
Hereditary Cancer | $ | 203.6 |  |  | $ | 35.3 |  |  | $ | 238.9 |  |  |  | $ | 190.6 |  |  | $ | 30.0 |  |  | $ | 220.6 |
Tumor Profiling | 78.1 |  |  | 25.4 |  |  | 103.5 |  |  |  | 61.4 |  |  | 35.5 |  |  | 96.9 |
Prenatal | 110.8 |  |  | 0.5 |  |  | 111.3 |  |  |  | 86.7 |  |  | 0.6 |  |  | 87.3 |
Pharmacogenomics | 102.9 |  |  | — |  |  | 102.9 |  |  |  | 95.5 |  |  | — |  |  | 95.5 |
Autoimmune | — |  |  | — |  |  | — |  |  |  | 0.3 |  |  | — |  |  | 0.3 |
Total revenue | $ | 495.4 |  |  | $ | 61.2 |  |  | $ | 556.6 |  |  |  | $ | 434.5 |  |  | $ | 66.1 |  |  | $ | 500.6 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration